Laurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma

MT Newswires Live

2025/03/17

Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.

The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.

According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.

Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2520255130"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2520255130\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2520255130?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-17 11:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2520255130","market":"sh","top_or_hot":-1,"title":"Laurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma","media":"MT Newswires Live","content":"<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.</p><p>The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.</p><p>According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.</p><p>Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Laurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLaurus Labs Completes Investment of INR833 Million in Joint Venture Company KRKA Pharma\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-17 11:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.</p><p>The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.</p><p>According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.</p><p>Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4185","symbol_name":"保健护理机构","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2520255130","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2520255130","pubTimestamp":1742181966,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Laurus Labs  has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4185":"保健护理机构","JYNT":"The Joint Corp."},"translate_title":"Laurus Labs完成对合资公司KRKA Pharma的8.33亿印度卢比投资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JYNT":1},"content_text":"Laurus Labs (NSE:LAURUSLABS, BOM:540222) has completed an investment of 833 million Indian rupees in its joint venture company KRKA Pharma, according to a Saturday filing to the Indian stock exchanges.The company has acquired 83,300,000 equity shares of KRKA at a face value of 10 rupees via a rights issue.According to a disclosure earlier in the month, Laurus Lab's joint venture partner KRKA d.d., Novo mesto, Slovenia will also invest 867 million rupees in KRKA.Both joint venture partners will maintain their shareholding ratio of 51:49 between KRKA d.d., Novo mesto, and Laurus Labs.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}